Astrazeneca Plc
General ticker "AZNCF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $206.5B
Astrazeneca Plc follows the US Stock Market performance with the rate: 12.6%.
Estimated limits based on current volatility of 2.0%: low 126.97$, high 132.14$
Factors to consider:
- Company pays dividends: last record date 2024-08-09, amount 0.98$ (Y2.96%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [94.39$, 144.07$]
- 2024-12-30 to 2025-12-30 estimated range: [91.13$, 141.44$]
Financial Metrics affecting the AZNCF estimates:
- Positive: Non-GAAP EPS, $ of 3.83 > 2.29
- Positive: 9.05 < Operating profit margin, % of 17.46
- Positive: -3.48 < Investing cash flow per share, $ of -2.62
- Negative: Interest expense per share, $ of 1.03 > 0.74
Short-term AZNCF quotes
Long-term AZNCF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $37,417.00MM | $44,351.00MM | $45,811.00MM |
| Operating Expenses | $36,361.00MM | $40,594.00MM | $37,618.00MM |
| Operating Income | $1,056.00MM | $3,757.00MM | $8,193.00MM |
| Non-Operating Income | $-1,321.00MM | $-1,256.00MM | $-1,294.00MM |
| Interest Expense | $1,300.00MM | $1,346.00MM | $1,589.00MM |
| R&D Expense | $9,736.00MM | $9,762.00MM | $11,015.00MM |
| Income(Loss) | $-265.00MM | $2,501.00MM | $6,899.00MM |
| Taxes | $-377.00MM | $-787.00MM | $944.00MM |
| Profit(Loss) | $112.00MM | $3,288.00MM | $5,955.00MM |
| Stockholders Equity | $39,268.00MM | $37,037.00MM | $39,143.00MM |
| Inventory | $8,983.00MM | $4,699.00MM | $5,424.00MM |
| Assets | $105,363.00MM | $96,483.00MM | $101,119.00MM |
| Operating Cash Flow | $5,963.00MM | $9,808.00MM | $10,345.00MM |
| Capital expenditure | $2,200.00MM | $2,571.00MM | $3,778.00MM |
| Investing Cash Flow | $-11,058.00MM | $-2,960.00MM | $-4,064.00MM |
| Financing Cash Flow | $3,649.00MM | $-6,823.00MM | $-6,567.00MM |
| Earnings Per Share* | $0.08 | $2.09 | $3.84 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.